Харвестер відкритої науки НАН України

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells

von Todor, I.N., Lukianova, N.Yu., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2012)

The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome

von Timovska, Yu., Pivnyuk, V., Todor, I., Anikusko, N., Chekhun, V.
Veröffentlicht in Experimental Oncology (2011)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs

von Yalovenko, T.M., Todor, I.M., Lukianova, N.Y., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2016)

Biomagnetism of tumor in rats with Guerin’s carcinoma after injection of ferromagnetic nanocomposite (Ferroplat): contactless measurement

von Todor, I.N., Lukianova, N.Yu., Primin, M.А., Nedayvoda, I.V., Chekhun, V.F.
Veröffentlicht 2023

БІОМАГНЕТИЗМ ЧУТЛИВИХ ТА РЕЗИСТЕНТНИХ ДО ЦИТОСТАТИКІВ ЗЛОЯКІСНИХ ПУХЛИН ПІСЛЯ ВВЕДЕННЯ ФЕРОМАГНІТНОГО НАНОКОМПОЗИТУ...

von Todor, I.N., Lukianova, N.Yu., Primin, M.A., Nedayvoda, I.V., Chekhun, V.F.
Veröffentlicht 2023

Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin

von Todor, I.N., Lukianova, N.Yu., Shvets, Yu.V., Lozovska, Yu.V., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2015)

Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats

von Chekhun, V.F., Storchai, D.M., Todor, I.N., Borikun, T.V., Lukianova, N.Yu.
Veröffentlicht in Experimental Oncology (2018)

Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards CIS-DDP resistance

von Pyaskovskaya, O.N., Dasyukevich, O.I., Kolesnik, D.L., Garmanchouk, L.V., Todor, I.N., Solyanik, G.I.
Veröffentlicht in Experimental Oncology (2007)

Pharmacological effect of aminoferrocene in mice with L1210 leukemia

von Chekhun, V.F., Mokhir, A., Daum, S., Todor, I.N., Lukianova, N.Yu., Shvets, Yu.V., Burlaka, A.P.
Veröffentlicht in Experimental Oncology (2015)

Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin

von Chekhun, V.F., Lozovska, Y.V., Burlaka, A.P., Lukyanova, N.Y., Todor, I.N., Naleskina, L.A.
Veröffentlicht in Experimental Oncology (2014)

Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factor

von Shevchuk, O.O., Posokhova, K.A., Todor, I.N., Lukianova, N.Yu., Nikolaev, V.G., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2015)

Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticles

von Yurchenko, O.V., Todor, I.N., Khayetsky, I.K., Tregubova, N.A., Lukianova, N.Yu., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2010)

Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatin

von Naleskina, L.A., Todor, I.N., Nosko, M.M., Lukianova, N.Yu., Pivnyuk, V.M., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2013)

The influence of lactoferrin on elemental homeostasis and activity of metal-containing enzymes in rats with Walker-256 carcinosarcoma

von Lozovska, Yu.V., Andrusishina, I.M., Lukianova, N.Yu., Burlaka, A.P., Naleskina, L.A., Todor, I.N., Chekhun, V.F.
Veröffentlicht 2023

Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism

von Chekhun, V.F., Todor, I.N., Lukianova, N.Yu., Horbyk, D.M., Lozovskaya, Yu.V., Burlaka, A.P., Borikun, T.V.
Veröffentlicht 2018

Green tea, red wine and lemon extracts reduce experimental tumor growth and cancer drug toxicity

von Zaletok, S., Gulua, L., Wicker, L., Shlyakhovenko, V., Gogol, S., Orlovsky, O., Karnaushenko, O., Verbinenko, A., Milinevska, V., Samoylenko, O., Todor, I., Turmanidze, T.
Veröffentlicht in Experimental Oncology (2015)

The use of nanoferromagnetics to increase the cytotoxic effect of antitumor drugs

von Chekhun, V.F., Todor, I.N., Lukyanova, N.Yu., Shpyleva, S.I., Naleskina, L.A., Khaetsky, I.K., Kulik, G.I.
Veröffentlicht in Experimental Oncology (2009)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor

von Tkalia, I.G., Vorobyova, L.I., Grabovoy, A.N., Svintsitsky, V.S., Tarasova, T.О., Lukyanova, N.Y., Todor, I.N., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2014)

Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma

von Potebnya, G.P., Voeykova, I.M., Lisovenko, G.S., Cheremshenko, N.L., Todor, I.M., Yudina, O.Yu., Kovtonyuk, O.V., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2009)

Gold nanoparticles synthesis and biological activity estimation in vitro and in vivo

von Rieznichenko, L.S., Dybkova, S.M., Gruzina, T.G., Ulberg, Z.R., Todor, I.N., Lukyanova, N.Yu., Shpyleva, S.I., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2012)